A modified mannitol dehydrogenase and use thereof
By mutating the amino acid sequence of mannitol dehydrogenase and coupling it with recombinant strains, the coenzyme dependence and stability issues of MDH in biotransformation were resolved, enabling efficient and low-cost D-mannitol production.
Patent Information
- Application Number
- CN202610396017.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-30
- Publication Date
- 2026-07-03
- Estimated Expiration
- 2046-03-30
AI Technical Summary
Existing mannitol dehydrogenase (MDH) suffers from coenzyme dependence, high cost, poor stability, and low conversion efficiency in biotransformation methods, which limits its application in industrial production.
By performing specific site mutations on the amino acid sequence of mannitol dehydrogenase, including C37A, Q75V, Q176L, Q185N, E197R, F225M, Y244F, and Q300L, the enzyme activity and stability were improved. Furthermore, the transformation process was optimized by coupling recombinant strains with formate dehydrogenase.
It significantly improves the conversion rate of D-fructose to D-mannitol, reduces production costs, and enhances enzyme activity and stability, making it suitable for large-scale industrial production.